Privia Health Group, Inc. updated earnings guidance for the full year 2023. For the year, the company expected revenue to be at the mid to high end of the previously provided range of $1,550 million to $1,650 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.99 USD | +0.11% | -5.71% | -21.88% |
05-10 | UBS Adjusts Privia Health Group Price Target to $26.50 From $29, Maintains Buy Rating | MT |
05-09 | Transcript : Privia Health Group, Inc., Q1 2024 Earnings Call, May 09, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.88% | 2.14B | |
+17.18% | 85.55B | |
-28.48% | 70.07B | |
+6.76% | 28.95B | |
-7.44% | 17.51B | |
+2.14% | 17.39B | |
+2.10% | 15.38B | |
+7.02% | 13.4B | |
+64.96% | 12.93B | |
+6.64% | 12.77B |
- Stock Market
- Equities
- PRVA Stock
- News Privia Health Group, Inc.
- Privia Health Group, Inc. Updates Earnings Guidance for the Full Year 2023